Home » Newsletters » BioWorld Science

BioWorld Science

May 22, 2001

View Archived Issues

Agile Therapeutics to evaluate once-weekly contraceptive patch in phase II trials

Zonagen's lead SPRM shows potential in treatment of endometriosis

Pipeline and program update provided by Texas Biotechnology

N-Acetylcysteine deserves further evaluation in Crohn's disease according to pilot study

CancerVax therapeutic vaccine significantly increases survival in late-stage cancers

Biota acquires NuMAX

Pharmacia's Vestra deemed not approvable by FDA

NitroMed's NO-donating proton pump inhibitors proven superior to lansoprazole in ulcer models

Promising preliminary results reported for AGI-1067 in postangioplasty restenosis

TAK-637, a selective, nonpeptide NK1 antagonist for IBS

Cambridge Antibody Technology reviews product pipeline

ETA antagonist delays disease progression, improves quality of life in late-stage prostate cancer

Company Profile: ALviva

Interim results of two Revimid studies presented at Myeloma Workshop

Vertex ICE inhibitor may have promise in inflammatory and autoimmune skin diseases

Preclinical studies support further testing of noscapine in malignant melanoma

Interferon Sciences licenses novel approach for prevention of tumor recurrence

ATS 2001: AWD-12-281 has beneficial effects on mucus secretion and lung neutrophilia

New research broadens understanding of mechanism of action for SAANDs

Obesity-related gene, methods for diagnosis and treatment of obesity, disclosed in recent patent

Adhesion receptor antagonists reported by Merck as useful in thrombotic disorders

Potential antidepressants in the GSK pipeline

Synthesis and use of azepinoindole PARP inhibitors in neurodegenerative disorders

Antiischemic adenosine agonists designed by Pfizer

Two patents issued for Lilly's new serotonergic piperidine derivatives

GlycoDesign and Leo select antithrombotic drug candidates

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Drug duo to Repare lack in gyno cancers? Phase I shows promise
BioWorld
Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.